Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report) shares dropped 4% during mid-day trading on Friday . The company traded as low as $1.44 and last traded at $1.44. Approximately 100 shares traded hands during trading, a decline of 96% from the average session volume of 2,831 shares. The stock had previously closed at $1.50.
Ascletis Pharma Price Performance
The firm’s fifty day moving average price is $1.61 and its 200 day moving average price is $1.79.
Ascletis Pharma Company Profile
Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.
The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Further Reading
- Five stocks we like better than Ascletis Pharma
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
